These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 353228)

  • 1. Identification and quantification of 3-methoxy-4-hydroxyphenylethanol (MOPET) in human cerebrospinal fluid and rat brain by means of gas chromatography-mass spectrometry.
    Muskeit FA; Jeuring HJ; Adèr JP; Wolthers BG
    J Neurochem; 1978 Jun; 30(6):1495-9. PubMed ID: 353228
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of probenecid on the free and conjugaed 3-methoxy-4-hydroxyphenylglycol (MHPG) in lumbar cerebrospinal fluid.
    Karoum F; van Kammen DP; Bunney WE; Gillin JC; Jimerson DC; Post RM; Wyatt RJ
    Psychopharmacol Commun; 1976; 2(2):141-8. PubMed ID: 790476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced alterations of 3-methoxy-4-hydroxyphenylethanol (MHPE) in rat brain.
    Waterbury LD; Wendel OT; Pearce LA
    Biochem Med; 1973 Aug; 8(1):61-71. PubMed ID: 4744322
    [No Abstract]   [Full Text] [Related]  

  • 4. Gas chromatographic evidence for the presence of 3-methoxy-4-hydroxyphenylethanol in rat brain.
    Braestrup C
    Biochem Pharmacol; 1972 Jun; 21(12):1775-6. PubMed ID: 4649134
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of L-DOPA on the excretion of alcoholic metabolites of catecholamines and trace amines in rat and human urine.
    Edwards DJ; Rizk M; Spiker DG
    Biochem Med; 1981 Apr; 25(2):135-48. PubMed ID: 6169341
    [No Abstract]   [Full Text] [Related]  

  • 6. Free 3-methoxy-4-hydroxyphenylethyleneglycol in the central nervous system of the rat: semi-automated fluorometric assay, turnover and effects of drugs.
    Adèr JP; Korf J
    J Neurochem; 1979 Jun; 32(6):1761-8. PubMed ID: 376782
    [No Abstract]   [Full Text] [Related]  

  • 7. Parkinsonism induced by dopaminergic antagonists.
    Hornykiewicz O
    Adv Neurol; 1975; 9():155-64. PubMed ID: 1096571
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of 3,4-dihydroxyphenylethyleneglycol in urine by gas chromatography with a flame ionization detector: a new rapid method.
    Biondi PA; Fedele G; Motta A; Secchi C
    Clin Chim Acta; 1979 Jun; 94(2):155-61. PubMed ID: 378468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal central monoamine metabolism in humans with "true hypersomnia" and "sub-wakefulness".
    Livrea P; Puca FM; Barnaba A; Di Reda L
    Eur Neurol; 1977; 15(2):71-6. PubMed ID: 323018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of thyrotropin-releasing hormone on neurologic recovery and biogenic amine metabolites of cerebrospinal fluid in spinal disorders].
    Hirofuji E; Tanaka S
    Nihon Seikeigeka Gakkai Zasshi; 1989 Nov; 63(11):1306-15. PubMed ID: 2515232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Methoxy-4-hydroxyphenylethanol in the rat brain.
    Braestrup C
    J Neurochem; 1973 Feb; 20(2):519-27. PubMed ID: 4698297
    [No Abstract]   [Full Text] [Related]  

  • 12. The formation of 3, 4-dihydroxyphenylethanol and 3-methoxy-4-hydroxyphenylethanol from 3, 4-dihydroxy-phenylethylamine in the rat.
    GOLDSTEIN M; FRIEDHOFF AJ; POMERANTZ S; CONTRERA JF
    J Biol Chem; 1961 Jun; 236():1816-21. PubMed ID: 13706661
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of 4-nitrocatechol in biodegradation samples by gas chromatography-mass spectrometry.
    Zdráhal Z
    J Chromatogr A; 1998 Jan; 793(1):214-9. PubMed ID: 9468658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and quantification of 3-methoxy-4-hydroxyphenyllactic acid (VLA) in cerebrospinal fluid and 3-methoxy-4-hydroxy phenylpyruvic acid (VPA) in the urine of Parkinsonian patients treated with L-DOPA.
    Muskiet FA; Jeuring HJ; Teelken AW; Wolthers BG; Lakke JP
    J Neurochem; 1978 Nov; 31(5):1283-8. PubMed ID: 702173
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of intraventricular injections of 6-hydroxydopamine on amine metabolites in rat brain and urine.
    Edwards DJ; Ravitch J; Knopf S; Sedlock ML
    Biochem Pharmacol; 1985 Apr; 34(8):1255-63. PubMed ID: 2581581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of amphetamine in plasma and cerebrospinal fluid by gas chromatography-mass spectrometry-selected ion monitoring, using beta-methylphenethylamine as in internal standard.
    Narasimhachari N; Friedel RO; Schlemmer F; Davis JM
    J Chromatogr; 1979 Nov; 164(3):386-93. PubMed ID: 120872
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of tryptamine in brain tissue by capillary gas chromatography mass spectrometry (selected ion monitoring).
    Artigas F; Suñol C; Tusell JM; Martínez E; Gelpí E
    Biomed Mass Spectrom; 1984 Mar; 11(3):142-4. PubMed ID: 6722286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of rat brain phenol sulphotransferase in vitro by noradrenaline and dopamine metabolites.
    Pennings EJ; Vrielink R; Wolters WL; Van Kempen GM
    J Neurochem; 1976 Oct; 27(4):915-20. PubMed ID: 787475
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of endogenous tryptamine in rat brain by capillary column gas chromatography mass spectrometry.
    Beck O; Flodberg G
    Biomed Mass Spectrom; 1984 Apr; 11(4):155-8. PubMed ID: 6733254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of indoles and catechols in rat brain and pineal using liquid chromatography with fluorometric and amperometric detection.
    Anderson GM; Young JG; Batter DK; Young SN; Cohen DJ; Shaywitz BA
    J Chromatogr; 1981 May; 223(2):315-20. PubMed ID: 7251785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.